REFERENCES
1. Rajashekar D, Liang JW. . Intracerebral hemorrhage. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021.
4. McEvoy AW, Kitchen ND, Thomas DG. Lesson of the week: intracerebral haemorrhage in young adults: the emerging importance of drug misuse. BMJ 2000;320:1322-4.
6. Qureshi AI, Qureshi MH. Acute hypertensive response in patients with intracerebral hemorrhage pathophysiology and treatment. J Cereb Blood Flow Metab 2018;38:1551-63.
7. Davis SM, Broderick J, Hennerici M, et al. Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006;66:1175-81.
8. Majidi S, Suarez JI, Qureshi AI. Management of acute hypertensive response in intracerebral hemorrhage patients after ATACH-2 trial. Neurocrit Care 2017;27:249-58.
9. Terayama Y, Tanahashi N, Fukuuchi Y, Gotoh F. Prognostic value of admission blood pressure in patients with intracerebral hemorrhage. Keio Cooperative Stroke Study. Stroke 1997;28:1185-8.
10. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Tanaka R. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 1998;29:1160-6.
11. Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 2004;35:1364-7.
12. Sang YH, Su HX, Wu WT, So KF, Cheung RT. Elevated blood pressure aggravates intracerebral hemorrhage-induced brain injury. J Neurotrauma 2011;28:2523-34.
13. Dastur CK, Yu W. Current management of spontaneous intracerebral haemorrhage. Stroke Vasc Neurol 2017;2:21-9.
14. Biffi A, Anderson CD, Battey TW, et al. Association between blood pressure control and risk of recurrent intracerebral hemorrhage. JAMA 2015;314:904-12.
15. Qureshi AI, Ezzeddine MA, Nasar A, et al. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med 2007;25:32-8.
16. Brott T, Thalinger K, Hertzberg V. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 1986;17:1078-83.
17. Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation 2008;118:176-87.
18. Fischer U, Cooney MT, Bull LM, et al. Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study. Lancet Neurol 2014;13:374-84.
19. Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997;28:2370-5.
20. Mayer SA, Brun NC, Begtrup K, et al. FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008;358:2127-37.
21. de Gasparo M, Speth RC, Baltatu OC, Vanderheyden P. Brain RAS: hypertension and beyond. Int J Hypertens 2013;2013:157180.
22. Morishita R, Higaki J, Okunishi H, et al. Role of tissue renin angiotensin system in two-kidney, one-clip hypertensive rats. Am J Physiol 1993;264:F510-4.
23. Kamińska M, Mogielnicki A, Stankiewicz A, Kramkowski K, Domaniewski T, Buczko W, Chabielska E. Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats. J Physiol Pharmacol 2005;56:571-85.
24. Wakisaka Y, Chu Y, Miller JD, Rosenberg GA, Heistad DD. Critical role for copper/zinc-superoxide dismutase in preventing spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice. Stroke 2010;41:790-7.
25. Wakisaka Y, Chu Y, Miller JD, Rosenberg GA, Heistad DD. Spontaneous intracerebral hemorrhage during acute and chronic hypertension in mice. J Cereb Blood Flow Metab 2010;30:56-69.
26. Ito H, Takemori K, Suzuki T. Role of angiotensin II type 1 receptor in the leucocytes and endothelial cells of brain microvessels in the pathogenesis of hypertensive cerebral injury. J Hypertens 2001;19:591-7.
27. Lanz TV, Ding Z, Ho PP, et al. Angiotensin II sustains brain inflammation in mice via TGF-beta. J Clin Invest 2010;120:2782-94.
28. Wosik K, Cayrol R, Dodelet-Devillers A, et al. Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis. J Neurosci 2007;27:9032-42.
29. Miyoshi M, Miyano K, Moriyama N, Taniguchi M, Watanabe T. Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor kappaB and activator protein-1 activation. Eur J Neurosci 2008;27:343-51.
30. Ando H, Zhou J, Macova M, Imboden H, Saavedra JM. Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats. Stroke 2004;35:1726-31.
31. Tanaka J, Hayashi Y, Watai T, Hori K, Nomura M. Noradrenaline release in the rat subfornical organ area to blood pressure changes. Exp Neurol 1998;152:303-6.
32. Iwata M, Inoue S, Kawaguchi M, Nakamura M, Konishi N, Furuya H. Posttreatment but not pretreatment with selective beta-adrenoreceptor 1 antagonists provides neuroprotection in the hippocampus in rats subjected to transient forebrain ischemia. Anesth Analg 2010;110:1126-32.
33. Goyagi T, Kimura T, Nishikawa T, Tobe Y, Masaki Y. Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats. Anesth Analg 2006;103:658-63.
34. Benveniste H, Kim KR, Hedlund LW, Kim JW, Friedman AH. Cerebral hemorrhage and edema following brain biopsy in rats: significance of mean arterial blood pressure. J Neurosurg 2000;92:100-7.
35. Bath P, Chalmers J, Powers W, et al. International Society of Hypertension Writing Group. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 2003;21:665-72.
36. Quiñones-ossa GA, Durango-espinosa Y, Padilla-zambrano H, et al. The puzzle of spontaneous versus traumatic intracranial hemorrhages. Egypt J Neurosurg 2020:35.
37. Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995;26:21-4.
38. Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008;7:391-9.
39. Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. American Heart Association Stroke Council. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2015;46:2032-60.
40. Steiner T, Al-Shahi Salman R, Beer R, et al. European Stroke Organisation. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. Int J Stroke 2014;9:840-55.
41. Strandgaard S. Autoregulation of cerebral blood flow in hypertensive patients. The modifying influence of prolonged antihypertensive treatment on the tolerance to acute, drug-induced hypotension. Circulation 1976;53:720-7.
42. Xie X, Xu J, Gu H, et al. The J-curve association between systolic blood pressure and clinical outcomes in ischemic stroke or TIA: the BOSS study. Sci Rep 2017;7:14023.
43. Vemmos KN, Tsivgoulis G, Spengos K, et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med 2004;255:257-65.
44. Qureshi AI, Bliwise DL, Bliwise NG, Akbar MS, Uzen G, Frankel MR. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med 1999;27:480-5.
45. Zazulia AR, Diringer MN, Videen TO, et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab 2001;21:804-10.
46. Kim-Han JS, Kopp SJ, Dugan LL, Diringer MN. Perihematomal mitochondrial dysfunction after intracerebral hemorrhage. Stroke 2006;37:2457-62.
47. Powers WJ, Zazulia AR, Videen TO, et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 2001;57:18-24.
48. Qureshi AI, Palesch YY, Barsan WG, et al. ATACH-2 Trial Investigators and the Neurological Emergency Treatment Trials Network. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. N Engl J Med 2016;375:1033-43.
49. Anderson CS, Heeley E, Huang Y, et al. INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med 2013;368:2355-65.
50. Ye Z, Ai X, Zheng J, et al. Antihypertensive treatments for spontaneous intracerebral hemorrhage in patients with cerebrovascular stenosis: a randomized clinical trial (ATICHST). Medicine (Baltimore) 2017;96:e7289.
51. Anderson CS, Huang Y, Arima H, et al. INTERACT Investigators. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke 2010;41:307-12.
52. Koch S, Romano JG, Forteza AM, Otero CM, Rabinstein AA. Rapid blood pressure reduction in acute intracerebral hemorrhage: feasibility and safety. Neurocrit Care 2008;8:316-21.
53. Arima H, Anderson CS, Wang JG, et al. Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial Investigators. Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage. Hypertension 2010;56:852-8.
54. Qureshi AI, Palesch YY, Martin R, et al. Antihypertensive Treatment of Acute Cerebral Hemorrhage Study Investigators. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch Neurol 2010;67:570-6.
55. Steiner T, Kaste M, Forsting M, et al. Recommendations for the management of intracranial haemorrhage - part I: spontaneous intracerebral haemorrhage. The European stroke initiative writing committee and the writing committee for the EUSI executive committee. Cerebrovasc Dis 2006;22:294-316.
56. Spence JD, Del Maestro RF. Hypertension in acute ischemic strokes. Treat. Arch Neurol 1985;42:1000-2.
58. Treatment of Acute Cerebral Hemorrhage (ATACH) investigators. Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med 2010;38:637-48.
59. Butcher KS, Jeerakathil T, Hill M, et al. ICH ADAPT Investigators. The intracerebral hemorrhage acutely decreasing arterial pressure trial. Stroke 2013;44:620-6.
60. Carcel C, Wang X, Sato S, et al. INTERACT2 Investigators. Degree and timing of intensive blood pressure lowering on hematoma growth in intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial-2 results. Stroke 2016;47:1651-3.
61. Wang X, Arima H, Heeley E, et al. INTERACT2 Investigators. Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study. Hypertension 2015;65:1026-32.
62. Arima H, Heeley E, Delcourt C, et al. INTERACT2 Investigators, INTERACT2 Investigators. Optimal achieved blood pressure in acute intracerebral hemorrhage: INTERACT2. Neurology 2015;84:464-71.
63. Tsivgoulis G, Katsanos AH, Butcher KS, et al. Intensive blood pressure reduction in acute intracerebral hemorrhage: a meta-analysis. Neurology 2014;83:1523-9.
64. ENOS Trial Investigators. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet 2015;385:617-28.
65. Krishnan K, Scutt P, Woodhouse L, et al. Glyceryl trinitrate for acute intracerebral hemorrhage: results from the efficacy of nitric oxide in stroke (ENOS) trial, a subgroup analysis. Stroke 2016;47:44-52.
66. Gong FT, Yu LP, Gong YH, Zhang YX, Wang ZG, Yan CZ. Blood pressure control in ultra-early basal ganglia intracerebral hemorrhage. Eur Rev Med Pharmacol Sci 2015;19:412-5.
67. Dang B, Duan X, Wang Z, He W, Chen G. A therapeutic target of cerebral hemorrhagic stroke: matrix metalloproteinase-9. Curr Drug Targets 2017;18:1358-66.
68. Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care 2011;15:559-76.
69. Qureshi AI, Foster LD, Lobanova I, Huang W, Suarez JI. Intensive blood pressure lowering in patients with moderate to severe grade acute cerebral hemorrhage: post hoc analysis of antihypertensive treatment of acute cerebral hemorrhage (ATACH)-2 trial. Cerebrovasc Dis 2020;49:244-52.
70. Shi L, Xu S, Zheng J, Xu J, Zhang J. Blood pressure management for acute intracerebral hemorrhage: a meta-analysis. Sci Rep 2017;7:14345.
71. Lattanzi S, Cagnetti C, Provinciali L, Silvestrini M. How should we lower blood pressure after cerebral hemorrhage? Cerebrovasc Dis 2017;43:207-13.
72. Ankolekar S, Fuller M, Cross I, et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). Stroke 2013;44:3120-8.
73. Bath PM, Woodhouse LJ, Krishnan K, et al. Prehospital transdermal glyceryl trinitrate for ultra-acute intracerebral hemorrhage: data from the RIGHT-2 trial. Stroke 2019;50:3064-71.
74. Gioia L, Klahr A, Kate M, et al. The intracerebral hemorrhage acutely decreasing arterial pressure trial II (ICH ADAPT II) protocol. BMC Neurol 2017;17:100.
75. Qureshi A, Palesch Y. ATACH II Investigators. Expansion of recruitment time window in antihypertensive treatment of acute cerebral hemorrhage (ATACH) II trial. J Vasc Interv Neurol 2012;5:6-9.
76. Qureshi AI. Intracerebral hemorrhage specific intensity of care quality metrics. Neurocrit Care 2011;14:291-317.
77. Griffith DN, James IM, Newbury PA, Woollard ML. The effect of beta-adrenergic receptor blocking drugs on cerebral blood flow. Br J Clin Pharmacol 1979;7:491-4.
78. Bonten TN, Plaizier CE, Snoep JJ, Stijnen T, Dekkers OM, van der Bom JG. Effect of β-blockers on platelet aggregation: a systematic review and meta-analysis. Br J Clin Pharmacol 2014;78:940-9.
79. Puchstein C, Van Aken H, Anger C, Hidding J. Influence of urapidil on intracranial pressure and intracranial compliance in dogs. Br J Anaesth 1983;55:443-8.
80. Storck J, Ochs JG, Kirsten R. Effects of urapidil on 5-hydroxytryptamine induced platelet aggregation and on 14C-5-hydroxytryptamine uptake in platelets. Int J Clin Pharmacol Ther Toxicol 1990;28:303-8.
81. Spalding A, Vaitkevicius H, Dill S, MacKenzie S, Schmaier A, Lockette W. Mechanism of epinephrine-induced platelet aggregation. Hypertension 1998;31:603-7.
82. Anfossi G, Trovati M, Mularoni E, Lanzio M, Massucco P, Emanuelli G. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction. Arch Int Pharmacodyn Ther 1988;296:144-54.
83. Akpek EA, Kahraman S, Yaman A, Bulutçu E, Yavuzer S, Ozgen S. The effect of pre-induction clonidine on platelet aggregation during minor surgery. Eur J Clin Pharmacol 1998;54:459-62.
84. Willmot M, Ghadami A, Whysall B, Clarke W, Wardlaw J, Bath PM. Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension 2006;47:1209-15.
85. Butterworth RJ, Cluckie A, Jackson SH, Buxton-Thomas M, Bath PM. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis 1998;8:158-65.
86. Bath PM, Pathansali R, Iddenden R, Bath FJ. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis 2001;11:265-72.
87. Bath PM, Scutt P, Anderson CS, et al. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Lancet 2019;393:1009-20.
88. Abe K, Iwanaga H, Inada E. Effect of nicardipine and diltiazem on internal carotid artery blood flow velocity and local cerebral blood flow during cerebral aneurysm surgery for subarachnoid hemorrhage. J Clin Anesth 1994;6:99-105.
89. Pearce WJ, Bevan JA. Diltiazem and autoregulation of canine cerebral blood flow. J Pharmacol Exp Ther 1987;242:812-7.
90. Walley TJ, Woods KL, Barnett DB. Effects of calcium channel blockers on in vitro platelet function in whole blood using single platelet counting. Thromb Haemost 1989;61:137-9.
91. Plangger C, Völkl H. Effect of furosemide, bumetanide and mannitol on intracranial pressure in experimental brain edema of the rat. Zentralbl Neurochir 1989;50:142-4.
